Back to search

Ireland· IE-PA-EU/1/13/829/001-007

Hexyon suspension for injection

A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b product containing (polyribosylribitol phosphate) conjugated to tetanous protein + type 1 (mahoney) + haemophilus influenzae type b polysaccharide + diphtheria toxoid, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 10 of our 19 countries.

ATC J07CA09

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedHexyon suspension for injectionATCJ07CA09REGISTER NO.IE-PA-EU/1/13/829/001…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b is registered in 10 of 19 countries.

Countries holding a registration under ATC J07CA09 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b · ATC J07CA09

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
(polyribosylribitol phosphate) conjugated to tetanous protein + Type 1 (mahoney) + Haemophilus influenzae type b polysaccharide + Diphtheria toxoid
Manufacturer
Sanofi Winthrop Industrie
Country
Ireland (IE)
ATC code
J07CA09
ATC class
Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/13/829/001-007

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ed8e978e-4220-4b89-9783-0b2147267bfe
GET /v1/drugs/ed8e978e-4220-4b89-9783-0b2147267bfe?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07CA",
    "J07CA09"
  ],
  "strength": null,
  "pa_number": "EU/1/13/829/001-007",
  "substances": [
    "(polyribosylribitol phosphate) conjugated to tetanous protein",
    "Type 1 (mahoney)",
    "Haemophilus influenzae type b polysaccharide",
    "Diphtheria toxoid",
    "Type 2 (mef-1)",
    "Filamentous haemagglutinin",
    "Tetanus toxoid",
    "Pertussis toxoid",
    "Type 3 (saukett)",
    "Hepatitis b surface antigen"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "17/04/2013",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.